跳至主要内容
临床试验/IRCT20120415009472N28
IRCT20120415009472N28招募中3 期

The effect of grape seed extract on the expression of genes mediating immunity, inflammation, disease severity and quality of life in patients with ulcerative colitis

Iran University of Medical Sciences0 个研究点目标入组 86 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
86

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • BMI of patients between 18.5-35 kg/m2
  • Diagnosis of ulcerative colitis in the mild to moderate stage by a gastroenterologist based on patient tests, patient symptoms (disease severity questionnaire)and colonoscopy.
  • Patients using only one of the drug groups (5-aminosalicylic acid (Petasa, Mesalazine or Asacol), as well as Azathioprine.

排除标准

  • Pregnancy and breastfeeding
  • Taking anticoagulants such as warfarin or heparin
  • Suffering from other intestinal diseases, autoimmune diseases, cancer, inflammatory diseases, and infectious diseases.

研究者

相似试验

The effect of grape seed extract in ulcerative... | 临床试验